Indian Journal of Pharmacology Home 

LETTER TO EDITOR
[Download PDF]
Year : 2011  |  Volume : 43  |  Issue : 1  |  Page : 94-

Author's reply

Sangeeta Sharma 
 Department of Neuropsychopharmacology, Institute of Human Behaviour and Allied Sciences, India

Correspondence Address:
Sangeeta Sharma
Department of Neuropsychopharmacology, Institute of Human Behaviour and Allied Sciences
India




How to cite this article:
Sharma S. Author's reply.Indian J Pharmacol 2011;43:94-94


How to cite this URL:
Sharma S. Author's reply. Indian J Pharmacol [serial online] 2011 [cited 2021 Apr 18 ];43:94-94
Available from: https://www.ijp-online.com/text.asp?2011/43/1/94/75688


Full Text

Sir,

This is with reference to the comments on our article [1] . The limitation of the study is mentioned in the discussion. Similar experiences have been reported by other authors in this area [2],[3] where a response rate ranging from 38%-70% was reported. We agree with the comments regarding generalization of findings from such studies and suggested measures to increase the response rate. Due care was taken with regard to design and layout of the questionnaire and pilot testing. A well sensitized, trained post graduate researcher collected the data after seeking appointment with the respondents recognizing time constraints etc.

Despite a low response rate, we feel the data is important to be shared as it reflects the initial trends pertaining to a very important but neglected area. If it is able to inspire more such studies the publication would have achieved at least a part of its objective i.e., eliciting the attitude and opinion towards essential medicine formulary to bring about further positive change. A low response rate may also be indication of a primary indifference towards the subject. Response elicited by persuasive methods may not be true and honest. We feel that the data presented reflects a primary uninfluenced response.

References

1Sharma S, Kh R, Chaudhury RR. Attitude and opinion towards essential medicine formulary. Indian J Pharmacol 2010;42:150-2.
2McGavock H, Wilson-Davis K, McGavoack SA - Formulary revision: eliciting the opinion of users. Br J Gen Pract 1996;46:419-21.
3Harding JM, Modell M. Freudenberg S, MacGregor R, Rea JN, Steen C, et al - Prescribing: the power to set limits. BMJ (Clin Res Ed) 1985;290:450-3.